SCM
Sio Capital Management Portfolio holdings
AUM
$395M
1-Year Est. Return
196.27%
1 Year Est. Return
+196.27%
AUM
$249M
AUM Growth
-$81M
(-25%)
Holding
64
Top Buys
| 1 | +$14.2M | |
| 2 | +$11.2M | |
| 3 | +$9.06M | |
| 4 |
Edgewise Therapeutics
EWTX
|
+$7.08M |
| 5 |
Maximus
MMS
|
+$5.6M |
Top Sells
| 1 | +$35.6M | |
| 2 | +$21.2M | |
| 3 | +$19.5M | |
| 4 |
Teleflex
TFX
|
+$14.9M |
| 5 |
Neurocrine Biosciences
NBIX
|
+$10.9M |
Sector Composition
| 1 | Healthcare | 83.62% |
| 2 | Industrials | 15.44% |
| 3 | Technology | 0.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ETNB
51
DELISTED
89bio
ETNB
| – | – |
-500,000
|
|
||
52
Haemonetics
HAE
$3.44B
| – | – |
-133,966
|
|
||
53
Icon
ICLR
$12.4B
| – | – |
-203,311
|
|
||
54
Idexx Laboratories
IDXX
$55.1B
| – | – |
0
|
|
||
55
INmune Bio
INMB
$37.8M
| – | – |
0
|
|
||
56
Ironwood Pharmaceuticals
IRWD
$511M
| – | – |
-1,017,616
|
|
||
57
Labcorp
LH
$22.1B
| – | – |
-83,873
|
|
||
58
Praxis Precision Medicines
PRAX
$4.66B
| – | – |
-112,500
|
|
||
59
Protara Therapeutics
TARA
$213M
| – | – |
-1,514,300
|
|
||
|
60
Teleflex
TFX
$4.73B
| – | – |
-107,780
|
|
||
|
VXRT
61
DELISTED
Vaxart
VXRT
| – | – |
-5,583,448
|
|
||
62
Zimmer Biomet
ZBH
$17.8B
| – | – |
-187,685
|
|
||
|
ATYR
63
aTyr Pharma
ATYR
$73.8M
| – | – |
0
|
|
||
64
Soleno Therapeutics
SLNO
$2.65B
| – | – |
0
|
|